Clearstead Advisors’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.2K Buy
+1,078
New +$40K ﹤0.01% 1556
2026
Q1
Sell
-34
Closed -$1.53K 2718
2025
Q4
$1.53K Sell
34
-79
-70% -$3.65K ﹤0.01% 2179
2025
Q3
$5.05K Hold
113
﹤0.01% 2154
2025
Q2
$5.43K Sell
113
-73
-39% -$3.17K ﹤0.01% 2083
2025
Q1
$7.47K Buy
+186
New +$7.82K ﹤0.01% 1683
2024
Q4
Sell
-408
Closed -$19.1K 2172
2024
Q3
$19.1K Hold
408
﹤0.01% 1434
2024
Q2
$17.3K Buy
+408
New +$17.9K ﹤0.01% 1414

Other funds holding QGEN

Clearstead Advisors's QGEN Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Qiagen (QGEN) in Q2 2026: 1,078 shares worth $42.2K. The stake represents ﹤0.01% of the portfolio and ranks #1556 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in QGEN as recently as Q4 2025.

Clearstead Advisors first reported a position in QGEN in Q2 2024 and has held it in 7 quarters since. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Clearstead Advisors held 1,078 shares of Qiagen worth $42.2K as of Q2 2026.
  • Qiagen was a new Clearstead Advisors position in Q2 2026.
  • Qiagen made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1556 holding.
  • Clearstead Advisors first reported a position in Qiagen in Q2 2024 and has held it in 7 quarters since.
  • 336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.